|
291
|
|
|
Ral guanine nucleotide dissociation stimulator |
RGDS, RGF, RalGEF |
|
|
292
|
|
|
RAN, member RAS oncogene family |
ARA24, Gsp1, TC4 |
|
|
293
|
|
|
RAN binding protein 1 |
HTF9A |
|
|
294
|
|
|
RAN binding protein 2 |
ADANE, ANE1, IIAE3, NUP358, TRP1, TRP2 |
|
|
295
|
|
|
Ran GTPase activating protein 1 |
Fug1, RANGAP, SD |
|
|
296
|
|
|
RAP1A, member of RAS oncogene family |
C21KG, G-22K, KREV-1, KREV1, RAP1, SMGP21 |
|
|
297
|
|
|
RAP1B, member of RAS oncogene family |
K-REV, RAL1B, THC11 |
|
|
298
|
|
|
RAP1 GTPase activating protein |
RAP1GA1, RAP1GAP1, RAP1GAPII, RAPGAP |
|
|
299
|
|
|
RAP2A, member of RAS oncogene family |
K-REV, KREV, RAP2, RbBP-30 |
|
|
300
|
|
|
Receptor associated protein of the synapse |
CMS11, CMS4C, FADS, FADS2, RAPSYN, RNF205 |
Alzheimer disease, Ankylosing spondylitis, Arthrogryposis multiplex congenita, Autoimmune disease, Congenital myasthenic syndrome, Fetal akinesia deformation sequence, Glaucoma, Global developmental delay, Hydrops fetalis, Major depressive disorder, Mood disorder, Obesity, Myasthenic syndrome, Myopathy, Neuromuscular diseases, Neurotic disorder, Open angle glaucoma, Osteoarthritis, Pena-shokeir syndrome type i, Postsynaptic congenital myasthenic syndrome, Prostate cancer, Diabetes mellitus, type 2View all (7 more) |